KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Charles River Laboratories International (CRL) over the last 11 years, with Q3 2025 value amounting to $49.9 million.

  • Charles River Laboratories International's Shares Outstanding (Diluted Average) fell 357.16% to $49.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.9 million, marking a year-over-year decrease of 357.16%. This contributed to the annual value of $51.6 million for FY2024, which is 34.4% up from last year.
  • As of Q3 2025, Charles River Laboratories International's Shares Outstanding (Diluted Average) stood at $49.9 million, which was down 357.16% from $50.1 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Shares Outstanding (Diluted Average) peaked at $51.8 million during Q2 2024, and registered a low of $49.9 million during Q3 2025.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $51.3 million, with a median of $51.4 million in 2021.
  • In the last 5 years, Charles River Laboratories International's Shares Outstanding (Diluted Average) surged by 221.95% in 2021 and then crashed by 357.16% in 2025.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Shares Outstanding (Diluted Average) stood at $51.4 million in 2021, then dropped by 0.24% to $51.3 million in 2022, then rose by 0.29% to $51.5 million in 2023, then increased by 0.34% to $51.6 million in 2024, then decreased by 3.41% to $49.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $49.9 million for Q3 2025, versus $50.1 million for Q2 2025 and $50.9 million for Q1 2025.